SK Capital Taps Ex-Emerson VP to Lead Portfolio Ops Push

SK Capital Partners just made a hire that says more about the state of private equity in specialty chemicals than any earnings report could.

The New York-based firm — which manages roughly $8 billion across materials, chemicals, and pharmaceuticals — brought in Jason Grapski as managing director for portfolio excellence. Grapski spent the last quarter-century at Emerson, most recently as vice president of global industry solutions, where he oversaw automation and digital transformation programs for industrial clients that look a lot like SK Capital's portfolio companies.

The move comes as chemical-focused PE firms face a tension that's becoming harder to ignore: portfolio companies are sitting on decades-old manufacturing infrastructure while customers demand the cost structure and agility of digitally native competitors. Hiring someone who spent 25 years teaching Fortune 500 industrials how to automate isn't window dressing — it's a signal that operational improvement is no longer about trimming headcount and renegotiating supplier contracts.

It's about rebuilding how these companies actually make things.

SK Capital's portfolio includes names like Nexeo Plastics, ANGUS Chemical, Innovint, and ASK Chemicals — mid-market specialty producers that serve industrial end markets where efficiency improvements directly hit EBITDA. These aren't software businesses where you can double productivity by shipping faster code. They're asset-heavy operations where a 200-basis-point margin gain requires rethinking decades of embedded process.

And the margin pressure is real. Raw material costs have been volatile since 2021. Labor costs are up. Environmental compliance is getting more expensive. Meanwhile, customers — especially in automotive, construction, and electronics — are demanding shorter lead times and more customization without paying premium pricing.

The traditional PE playbook for that scenario involves cost cuts and bolt-on acquisitions. But the firms winning in chemicals right now aren't just consolidating capacity — they're modernizing it. That means predictive maintenance systems that prevent unplanned downtime. Real-time production analytics that optimize batch runs. Supply chain visibility tools that cut working capital needs. The kind of operational infrastructure that Emerson sells to the largest industrials in the world.

Grapski built his career implementing exactly that stack. Before running global industry solutions, he led commercial operations for Emerson's process automation business and served as general manager for the company's measurement and analytical instrumentation division. Translation: he knows how to sell, deploy, and scale the digital tools that chemical manufacturers need but often don't have the internal talent to implement.

The title — managing director, portfolio excellence — is deliberately broad, but the role is specific. According to SK Capital's announcement, Grapski will work directly with portfolio company management teams to identify and execute operational improvements across manufacturing, supply chain, and commercial functions.

That's a different mandate than the traditional operating partner role, which often focuses on M&A integration or C-suite recruiting. This is about getting into the weeds of how a chemical plant runs and figuring out where technology can unlock margin without requiring new capex. It's the kind of work that doesn't generate press releases but can add 3-5 points of EBITDA margin over a hold period — which, in a $200 million revenue business, is the difference between a 2.0x and a 2.8x return.

The timing matters. SK Capital has been active — it closed SK Capital Partners Fund V at $2.4 billion in 2022 and has deployed capital steadily since. But exit multiples in specialty chemicals have compressed. Strategic buyers are paying 9-11x EBITDA for quality assets, down from 12-14x in 2021. That means the delta between a good exit and a mediocre one increasingly comes from operational performance, not multiple expansion.

Numbers like that explain why SK Capital is investing in operational talent now. If you can't rely on the market to lift valuations, you need to manufacture returns the old-fashioned way — by making the business objectively better.

Grapski's background at Emerson is relevant for reasons beyond his technical expertise. Emerson doesn't just sell automation hardware — it embeds itself in clients' operations, often running multi-year transformation programs that touch everything from plant floor systems to enterprise software. The company's clients include the exact type of mid-market chemical and materials businesses that populate SK Capital's portfolio.

SK Capital isn't alone in prioritizing operational muscle. Across specialty materials and industrials, PE firms are staffing up on the ops side — particularly in areas where technology adoption has lagged. AEA Investors, Court Square Capital Partners, and Arsenal Capital Partners have all added senior operating executives with industrial automation or supply chain digitization backgrounds in the past 18 months.

The shift reflects a broader realization: the companies that got bought in 2018-2021 often need more than financial engineering to hit plan. Many are family-owned businesses that professionalized under PE ownership but never fully modernized their operations. They have loyal customer bases, defensible market positions, and decent margins — but they're running on legacy ERP systems, making production decisions based on instinct rather than data, and leaving cash trapped in inventory because they can't forecast demand accurately.

Fixing that isn't a six-month project. It requires someone who understands both the technical stack and the organizational change management required to get plant managers and operators to trust new systems. That's the profile SK Capital just hired.

Barry Siadat, a partner at SK Capital, framed the hire as part of the firm's commitment to hands-on value creation. "Jason's extensive experience driving operational improvements and digital transformation across complex industrial organizations will be a tremendous asset to our portfolio companies," he said in the announcement.

Translation: we're not just backing management teams anymore — we're embedding expertise they don't have in-house.

One dimension the press release doesn't mention but that's quietly driving a lot of these hires: generative AI is starting to show real ROI in manufacturing operations, and chemical companies are behind the curve. Predictive maintenance, demand forecasting, and quality control optimization — all areas where Grapski has worked — are being reimagined with AI tools that require significantly less data infrastructure than older machine learning approaches.

The catch? Implementing those tools successfully requires someone who understands both the technology and the operational context. A plant manager isn't going to trust an AI-generated maintenance recommendation unless they understand the underlying logic. That's where someone with Grapski's background becomes valuable — he's spent years teaching industrial operators how to adopt new technology without breaking what already works.

In practice, Grapski will likely start by conducting operational assessments across SK Capital's active portfolio — identifying quick wins (process automation, inventory optimization) and longer-term transformation opportunities (ERP upgrades, digital twin implementations). The goal isn't to turn chemical companies into tech companies — it's to bring them up to the operational standard that strategic buyers now expect.

That matters because the exit environment has changed. Five years ago, a strategic acquirer might have discounted a target's operational inefficiencies, figuring they could fix it post-close. Today, with integration risk higher and financing more expensive, buyers are paying premiums for assets that are already optimized. A chemical business with modern production analytics, low working capital needs, and predictable output is worth 1-2 more turns than a comparable asset running on spreadsheets and gut feel.

For SK Capital, that's the bet. Hiring Grapski is an investment in making portfolio companies more sellable — not just more profitable. And in a market where exit timelines are stretching and buyers are pickier, that might be the smartest capital allocation decision the firm makes this year.

The hire also signals something else: the era of passive PE ownership in industrials is over. Firms that win in this environment will be the ones that can actually improve how their companies operate — not just how they're financed. Bringing in someone who's spent 25 years doing exactly that is a clear statement of intent.

Grapski's move also highlights a talent trend worth watching: senior executives from industrial technology companies are increasingly being recruited into PE operating roles. These aren't typical post-CEO advisory positions — they're active, hands-on roles where the exec is expected to embed with portfolio companies and drive tangible improvements.

For someone like Grapski, the appeal is straightforward. Instead of selling automation solutions to one client at a time, he's now working across a portfolio of companies where he can implement the same playbook repeatedly — and capture upside from the value creation he drives. For SK Capital, it's a way to differentiate in a competitive market by offering portfolio companies expertise they can't hire on their own.

SK Capital has historically positioned itself as a specialist in specialty materials and chemicals — sectors where operational expertise matters as much as deal sourcing. The firm's model centers on acquiring mid-market businesses with strong market positions but underutilized assets, then driving growth through a combination of organic improvements and strategic M&A.

Past exits suggest the model works. The firm sold H.I.G. Capital-backed Vertellus Specialties to an affiliate of SK Capital itself in 2019 for an undisclosed sum after driving margin expansion through operational improvements. It exited Nouryon's Performance Chemicals business in 2021 after a hold period where revenue grew 15% and EBITDA margins expanded by 400 basis points, driven in part by supply chain optimization and procurement efficiencies.

But those wins came during a period when exit multiples were rising and interest rates were near zero. The next set of realizations will need to be earned through operational performance, not market conditions. That's why the firm is staffing up now.

Grapski's appointment also comes as SK Capital prepares for the next fundraising cycle. Fund V is largely deployed, and the firm will eventually need to demonstrate to LPs that it can generate strong returns in a tougher environment. Operational improvements are easier to quantify and present in an LP meeting than "we rode the market up." Bringing in a senior ops leader now positions the firm to show tangible margin and efficiency gains across the portfolio when it's time to raise Fund VI.

A few things the announcement leaves unclear: How much capital will SK Capital allocate to operational improvements across the portfolio? Will Grapski have the authority to recommend capex investments, or is his mandate limited to process and systems improvements? And how will success be measured — EBITDA margin expansion, cash flow improvement, reduced unplanned downtime?

Those details matter because operational value creation is easy to talk about and hard to execute. It requires sustained investment — financial and human — and a willingness to disrupt existing management teams when necessary. The firms that do it well treat operational improvement as a core competency, not a bolt-on function. They staff multiple senior operators, not just one. They tie executive comp at portfolio companies to operational KPIs, not just revenue growth. And they're willing to extend hold periods if meaningful improvements take longer than expected.

If SK Capital is serious about this — and the Grapski hire suggests they are — the payoff could be substantial. But it won't show up in the next quarterly portfolio update. This is a long game.

The other question is whether this becomes a recruiting pattern. If Grapski succeeds in driving measurable improvements across SK Capital's portfolio, expect other chemical and materials-focused PE firms to start hiring similar profiles — and expect compensation for senior industrial ops talent to rise as a result.

Over the next 12-18 months, a few signals will indicate whether this hire is part of a real strategic shift or just a box-checking exercise. First, watch for follow-on hires. If SK Capital adds more operational talent — particularly in areas like supply chain, procurement, or digital transformation — that's a sign the firm is building a true operational capability, not just bringing in one senior advisor.

Second, watch for portfolio company capex announcements. If companies in SK Capital's portfolio start making investments in automation, analytics infrastructure, or production technology, that suggests Grapski has buy-in to drive real transformation — and that the firm is willing to fund it.

Third, watch exit multiples. If SK Capital starts realizing exits at 11-12x EBITDA in an environment where comps are trading at 9-10x, that's the proof point. It means the market is willing to pay a premium for operationally optimized assets — and that the investment in portfolio excellence is paying off.

Finally, watch for operational KPIs in SK Capital's LP reporting. The best operational value creation firms don't just report financial metrics — they report on-time delivery rates, production uptime, inventory turns, and other operational indicators that drive EBITDA. If SK Capital starts sharing those metrics publicly or in fundraising materials, it's a sign the firm is serious about repositioning as an operationally-focused investor.

For now, the hire is a statement of intent. But in private equity, intent only matters if it translates into returns. The next few years will show whether SK Capital's bet on portfolio excellence was strategy — or just good PR.

Zooming out, Grapski's appointment is one data point in a larger shift across industrial and chemical private equity. As the easy money era ends and firms face the prospect of longer hold periods and tougher exits, the competitive advantage is moving away from deal sourcing and toward value creation. The firms that figure out how to systematically improve operations — not just optimize capital structures — will be the ones that generate top-quartile returns over the next decade.

That's especially true in chemicals, where the asset base is aging, the competitive environment is intensifying, and customers are demanding more for less. The companies that win in that environment won't be the ones with the best financial sponsors — they'll be the ones with the best operations. And the PE firms that win will be the ones that can deliver that operational excellence at scale.

SK Capital just signaled it wants to be one of those firms.

Whether it succeeds depends on execution — but hiring Jason Grapski was a solid first move.